{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Clinicopathological stages", "Nasopharyngeal carcinoma", "Survival prognosis", "Survivin", "TCF-4", "\u03b2-Catenin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30867651", "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "02", "Day": "28"}], "Language": ["eng"], "ELocationID": ["48", "10.1186/s12935-019-0764-7"], "Journal": {"ISSN": "1475-2867", "JournalIssue": {"Volume": "19", "PubDate": {"Year": "2019"}}, "Title": "Cancer cell international", "ISOAbbreviation": "Cancer Cell Int"}, "ArticleTitle": "Roles of \u03b2-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance.", "Pagination": {"StartPage": "48", "MedlinePgn": "48"}, "Abstract": {"AbstractText": ["Nasopharyngeal carcinoma (NPC) is a common malignant tumor of the head and neck region with poorly understood progression and prognosis. The present study aims at exploring whether the expression of \u03b2-catenin, TCF-4, and survivin affects clinicopathological features and prognostic significance in NPC.", "We enrolled 164 patients with NPC and 70 patients with chronic nasopharyngitis (CNP) in this study. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry (IHC) were conducted to evaluate the expression of \u03b2-catenin, TCF-4, and survivin. Spearman's rank correlation analysis and Pearson correlation analysis were used to measure the correlation of \u03b2-catenin, TCF-4, and survivin. Risk factors for prognosis and survival conditions of NPC patients were analyzed by Cox proportional hazards model and Kaplan-Meier curves.", "The results obtained revealed that mRNA and protein expression of \u03b2-catenin, TCF-4, and survivin was higher in NPC tissues than in CNP tissues. Positive correlations amongst \u03b2-catenin, TCF-4, and survivin were identified by Spearman's rank correlation analysis and Pearson correlation analysis. There was a significant correlation in expression of \u03b2-catenin, TCF-4, and survivin with EBV DNA, EBV-VCA-IgA, EBV-EA-IgA, T stage, N stage, and clinicopathological stages. Lower overall survival (OS), distant metastasis-free survival (DMFS), local recurrence-free survival (LRFS), and disease-free survival (DFS) rates were detected in NPC patients with positive expression of \u03b2-catenin, TCF-4, and survivin, in contrast to those with negative expression. Cox proportional hazards model demonstrated that \u03b2-catenin, TCF-4, and survivin protein positive expression were independent risk factors for OS and DFS of NPC prognosis; there was an evident correlation between clinicopathological stages, TCF-4, and EBV-EA-IgA and OS, DMFS, LRFS, and DFS of NPC.", "The aforementioned results indicate that \u03b2-catenin, TCF-4, and survivin proteins are highly expressed in NPC, which can be used as factors to predict the malignancy of NPC. In addition, positive expression of \u03b2-catenin, TCF-4, and survivin are potential risk factors that lead to an unfavorable prognosis of OS and DFS in NPC patients."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0000 9698 6425", "grid.411857.e"], "Affiliation": "1Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, No. 101, Shanghai Road, Tongshan District, Xuzhou, 221116 Jiangsu People's Republic of China."}], "LastName": "Jin", "ForeName": "Pei-Ying", "Initials": "PY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0004 1765 1045", "grid.410745.3"], "Affiliation": "2State Key Laboratory Cultivation Base For TCM Quality and Efficacy, School of Medicine and Life Science, Nanjing University of Chinese Medicine, Nanjing, 210023 People's Republic of China."}], "LastName": "Zheng", "ForeName": "Zi-Hui", "Initials": "ZH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0000 9698 6425", "grid.411857.e"], "Affiliation": "1Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, No. 101, Shanghai Road, Tongshan District, Xuzhou, 221116 Jiangsu People's Republic of China."}], "LastName": "Lu", "ForeName": "Hong-Jie", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.413389.4"], "Affiliation": "3Emergency Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221009 People's Republic of China."}], "LastName": "Yan", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0000 9698 6425", "grid.411857.e"], "Affiliation": "1Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, No. 101, Shanghai Road, Tongshan District, Xuzhou, 221116 Jiangsu People's Republic of China."}], "LastName": "Zheng", "ForeName": "Gui-Hong", "Initials": "GH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0000 9698 6425", "grid.411857.e"], "Affiliation": "1Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, No. 101, Shanghai Road, Tongshan District, Xuzhou, 221116 Jiangsu People's Republic of China."}], "LastName": "Zheng", "ForeName": "Yuan-Lin", "Initials": "YL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0000 9698 6425", "grid.411857.e"], "Affiliation": "1Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, No. 101, Shanghai Road, Tongshan District, Xuzhou, 221116 Jiangsu People's Republic of China."}], "LastName": "Wu", "ForeName": "Dong-Mei", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0000 9698 6425", "grid.411857.e"], "Affiliation": "1Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, No. 101, Shanghai Road, Tongshan District, Xuzhou, 221116 Jiangsu People's Republic of China."}], "LastName": "Lu", "ForeName": "Jun", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cancer Cell Int", "NlmUniqueID": "101139795", "ISSNLinking": "1475-2867"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Cui Y, Zhang C, Luo R, Liu H, Zhang Z, Xu T, Zhang Y, Wang D. Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles. Int J Nanomed. 2016;11:5671\u20135682.", "ArticleIdList": ["PMC5117895", "27895477"]}, {"Citation": "Gourzones C, Gelin A, Bombik I, Klibi J, Verillaud B, Guigay J, Lang P, Temam S, Schneider V, Amiel C, Baconnais S, Jimenez AS, Busson P. Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J. 2010;7:271.", "ArticleIdList": ["PMC2974674", "20950422"]}, {"Citation": "Li JX, Lu TX, Huang Y, Han F. Clinical characteristics of recurrent nasopharyngeal carcinoma in high-incidence area. Sci World J. 2012;2012:719754.", "ArticleIdList": ["PMC3289855", "22448138"]}, {"Citation": "Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012\u20131024.", "ArticleIdList": ["26321262"]}, {"Citation": "Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer. 2011;30(2):114\u2013119.", "ArticleIdList": ["PMC4013340", "21272443"]}, {"Citation": "Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou ZX, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chin J Cancer. 2014;33(8):381\u2013387.", "ArticleIdList": ["PMC4135367", "25096544"]}, {"Citation": "Qu C, Liang Z, Huang J, Zhao R, Su C, Wang S, Wang X, Zhang R, Lee MH, Yang H. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle. 2012;11(4):785\u2013796.", "ArticleIdList": ["PMC3356830", "22374676"]}, {"Citation": "Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst. 2011;103(23):1761\u20131770.", "ArticleIdList": ["22056739"]}, {"Citation": "Wang WJ, Wu SP, Liu JB, Shi YS, Huang X, Zhang QB, Yao KT. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells. Cancer Res. 2013;73(3):1219\u20131231.", "ArticleIdList": ["23269272"]}, {"Citation": "Feng X, Lin J, Xing S, Liu W, Zhang G. Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma. BMC Cancer. 2017;17(1):90.", "ArticleIdList": ["PMC5286734", "28143425"]}, {"Citation": "Ren X, Yang X, Cheng B, Chen X, Zhang T, He Q, Li B, Li Y, Tang X, Wen X, Zhong Q, Kang T, Zeng M, Liu N, Ma J. HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma. Nat Commun. 2017;8:14053.", "ArticleIdList": ["PMC5296651", "28146149"]}, {"Citation": "Shi L, Yin W, Zhang Z, Shi G. Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1. FEBS Open Biol. 2016;6(12):1211\u20131219.", "ArticleIdList": ["PMC5302062", "28203521"]}, {"Citation": "Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13(1):11\u201326.", "ArticleIdList": ["23258168"]}, {"Citation": "Stepicheva N, Nigam PA, Siddam AD, Peng CF, Song JL. microRNAs regulate beta-catenin of the Wnt signaling pathway in early sea urchin development. Dev Biol. 2015;402(1):127\u2013141.", "ArticleIdList": ["PMC4433612", "25614238"]}, {"Citation": "Peter IS, Davidson EH. The endoderm gene regulatory network in sea urchin embryos up to mid-blastula stage. Dev Biol. 2010;340(2):188\u2013199.", "ArticleIdList": ["PMC3981691", "19895806"]}, {"Citation": "Bush BM, Brock AT, Deng JA, Nelson RA, Sumter TF. The Wnt/beta-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer. Cell Biochem Funct. 2013;31(3):228\u2013236.", "ArticleIdList": ["PMC3616152", "22961697"]}, {"Citation": "Huang J, Lyu H, Wang J, Liu B. MicroRNA regulation and therapeutic targeting of survivin in cancer. Am J Cancer Res. 2015;5(1):20\u201331.", "ArticleIdList": ["PMC4300714", "25628918"]}, {"Citation": "Ma F, Zhang H, Zhai Y, Huang W, Zhao C, Ou S, Zhou H, Yuan W, Wang Z, Wang H, Yue W, Yu L, Li P, Xia X, Cai M, Zhang Y, Cui Y, He F, Ma Y, Zhou G. Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese. PLoS ONE. 2011;6(2):e16748.", "ArticleIdList": ["PMC3033414", "21304814"]}, {"Citation": "Zhuang K, Yan Y, Zhang X, Zhang J, Zhang L, Han K. Gastrin promotes the metastasis of gastric carcinoma through the beta-catenin/TCF-4 pathway. Oncol Rep. 2016;36(3):1369\u20131376.", "ArticleIdList": ["27430592"]}, {"Citation": "Kim W, Kim M, Jho EH. Wnt/beta-catenin signalling: from plasma membrane to nucleus. Biochem J. 2013;450(1):9\u201321.", "ArticleIdList": ["23343194"]}, {"Citation": "Tuo YL, Li XM, Luo J. Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci. 2015;19(18):3403\u20133411.", "ArticleIdList": ["26439035"]}, {"Citation": "Qin J, Ji J, Deng R, Tang J, Yang F, Feng GK, Chen WD, Wu XQ, Qian XJ, Ding K, Zhu XF. DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2. Oncotarget. 2015;6(9):6944\u20136958.", "ArticleIdList": ["PMC4466661", "25749514"]}, {"Citation": "Wang W, Wen Q, Xu L, Xie G, Li J, Luo J, Chu S, Shi L, Huang D, Li J, Fan S. Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma. PLoS ONE. 2014;9(8):e106098.", "ArticleIdList": ["PMC4148345", "25165983"]}, {"Citation": "Yang LH, Xu HT, Han Y, Li QC, Liu Y, Zhao Y, Yang ZQ, Dong QZ, Miao Y, Dai SD, Wang EH. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells. Mol Cancer. 2010;9:25.", "ArticleIdList": ["PMC2827467", "20122174"]}, {"Citation": "Deol YS, Nasser MW, Yu L, Zou X, Ganju RK. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the beta-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells. J Biol Chem. 2011;286(52):44845\u201344854.", "ArticleIdList": ["PMC3248020", "22016394"]}, {"Citation": "Wu B, Piloto S, Zeng W, Hoverter NP, Schilling TF, Waterman ML. Ring Finger Protein 14 is a new regulator of TCF/beta-catenin-mediated transcription and colon cancer cell survival. EMBO Rep. 2013;14(4):347\u2013355.", "ArticleIdList": ["PMC3615654", "23449499"]}, {"Citation": "Song Y, Yang QX, Zhang F, Meng F, Li H, Dong Y, Han A. Suppression of nasopharyngeal carcinoma cell by targeting beta-catenin signaling pathway. Cancer Epidemiol. 2012;36(2):e116\u2013e121.", "ArticleIdList": ["22142772"]}, {"Citation": "Xu HT, Wei Q, Liu Y, Yang LH, Dai SD, Han Y, Yu JH, Liu N, Wang EH. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer. Ann Surg Oncol. 2007;14(11):3251\u20133259.", "ArticleIdList": ["17768662"]}, {"Citation": "Sun P, Xiong H, Kim TH, Ren B, Zhang Z. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells. Mol Pharmacol. 2006;69(2):520\u2013531.", "ArticleIdList": ["16291872"]}, {"Citation": "Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, George SJ. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Circ Res. 2006;99(12):1329\u20131337.", "ArticleIdList": ["17122440"]}, {"Citation": "Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O\u2019Sullivan B, Bastianutto C, Liu FF. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res. 2006;12(19):5726\u20135732.", "ArticleIdList": ["17020977"]}, {"Citation": "Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer. 2003;3(1):46\u201354.", "ArticleIdList": ["12509766"]}, {"Citation": "Huang Y, Rao H, Yan S, Wang F, Wu Q, Feng Y, Zhang Y. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution. Ann Hematol. 2017;96(8):1331\u20131342.", "ArticleIdList": ["PMC5486802", "28550598"]}, {"Citation": "Tomita M, Dewan MZ, Yamamoto N, Kikuchi A, Mori N. Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes. Cancer Sci. 2009;100(5):807\u2013812.", "ArticleIdList": ["19309363"]}, {"Citation": "Barker N, Huls G, Korinek V, Clevers H. Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. Am J Pathol. 1999;154(1):29\u201335.", "ArticleIdList": ["PMC1853446", "9916915"]}, {"Citation": "Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett. 2002;184(1):105\u2013116.", "ArticleIdList": ["12104054"]}, {"Citation": "Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F, Santambrogio L, Coggi G, Bosari S. Survivin gene expression in early-stage non-small cell lung cancer. J Pathol. 2003;200(5):620\u2013626.", "ArticleIdList": ["12898598"]}, {"Citation": "Takahashi M, Tsunoda T, Seiki M, Nakamura Y, Furukawa Y. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene. 2002;21(38):5861\u20135867.", "ArticleIdList": ["12185585"]}, {"Citation": "Lee SH, Koo BS, Kim JM, Huang S, Rho YS, Bae WJ, Kang HJ, Kim YS, Moon JH, Lim YC. Wnt/beta-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. J Pathol. 2014;234(1):99\u2013107.", "ArticleIdList": ["24871033"]}, {"Citation": "Chang HW, Lee YS, Nam HY, Han MW, Kim HJ, Moon SY, Jeon H, Park JJ, Carey TE, Chang SE, Kim SW, Kim SY. Knockdown of beta-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cell Signal. 2013;25(4):839\u2013847.", "ArticleIdList": ["23280187"]}, {"Citation": "Li CY, Wang Y, Cui ZS, Wang EH. Expression of T cell factor-4 in non-small-cell lung cancer. Chin Med J (Engl). 2005;118(2):136\u2013140.", "ArticleIdList": ["15667799"]}, {"Citation": "Jiang Y, Zhou XD, Liu YK, Wu X, Huang XW. Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma. World J Gastroenterol. 2002;8(5):804\u2013807.", "ArticleIdList": ["PMC4656565", "12378619"]}, {"Citation": "Guo L, Tang M, Yang L, Xiao L, Bode AM, Li L, Dong Z, Cao Y. Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma. Int J Mol Med. 2012;29(4):574\u2013580.", "ArticleIdList": ["PMC3573768", "22266808"]}, {"Citation": "Scheper MA, Nikitakis NG, Sauk JJ. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer. Int J Oral Maxillofac Surg. 2007;36(7):632\u2013639.", "ArticleIdList": ["17566705"]}, {"Citation": "Scheper MA, Sauk JJ, Nikitakis NG. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation. Anticancer Res. 2006;26(6B):4103\u20134113.", "ArticleIdList": ["17201121"]}, {"Citation": "Xiang Y, Yao H, Wang S, Hong M, He J, Cao S, Min H, Song E, Guo X. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma. Laryngoscope. 2006;116(1):126\u2013130.", "ArticleIdList": ["16481824"]}, {"Citation": "Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, O\u2019Sullivan B, Liu FF. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 2011;71(6):2381\u20132391.", "ArticleIdList": ["21385904"]}, {"Citation": "Han BL, Xu XY, Zhang CZ, Wu JJ, Han CF, Wang H, Wang X, Wang GS, Yang SJ, Xie Y. Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations. Asian Pac J Cancer Prev. 2012;13(6):2577\u20132581.", "ArticleIdList": ["22938423"]}, {"Citation": "Sun R, Wang X, Li X. Correlation Analysis of Nasopharyngeal Carcinoma TNM Staging with Serum EA IgA and VCA IgA in EBV and VEGF-C and -D. Med Sci Monit. 2015;21:2105\u20132109.", "ArticleIdList": ["PMC4514295", "26191775"]}, {"Citation": "Zhang Y, Lang JY, Liu L, Wang J, Feng G, Jiang Y, Deng YL, Wang XJ, Yang YH, Dai TZ, Xie G, Pu J, Du XB. Association of nuclear factor kappaB expression with a poor outcome in nasopharyngeal carcinoma. Med Oncol. 2011;28(4):1338\u20131342.", "ArticleIdList": ["20499210"]}]}], "History": [{"Year": "2018", "Month": "10", "Day": "22"}, {"Year": "2019", "Month": "2", "Day": "21"}, {"Year": "2019", "Month": "3", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "2", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["30867651", "PMC6396483", "10.1186/s12935-019-0764-7", "764"]}}]}